Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.64 |
| ▸ | MAPT | P10636 | 2/20 | 0.64 |
| ▸ | JAK2 | O60674 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.58 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
| ▸ | HTR2B | P41595 | 1/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.52 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.51 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1835312 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL1838728 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL9048074 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL6276541 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL1836622 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL1834963 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL1834630 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL270163 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL22207144 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 | |
| SCHEMBL1837357 | 1.00 | LMNA (0.64) | LMNAMAPTJAK2GAAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378205-B2 | Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof | BASF SE (DE) | 2025-08-05 | — | — | US | disclosed |
| US-12291509-B2 | Process for the preparation of UV absorbers | BASF SE (DE) | 2025-05-06 | — | — | US | disclosed |
| EP-3908576-B1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF SE (DE) | 2023-03-08 | — | — | EP | disclosed |
| US-20220119357-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| US-20220064129-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2022-03-03 | — | — | US | disclosed |
| EP-3908576-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF SE (DE) | 2021-11-17 | — | — | EP | disclosed |
| EP-3908633-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | BASF SE (DE) | 2021-11-17 | — | — | EP | disclosed |
| CN-113260679-A | Process for preparing triazine intermediates and process for preparing UV absorbers thereof | 巴斯夫欧洲公司 | 2021-08-13 | — | — | CN | disclosed |
| CN-113260611-A | Method for producing UV absorbers | 巴斯夫欧洲公司 | 2021-08-13 | — | — | CN | disclosed |
| WO-2020144093-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | BASF SE (DE) | 2020-07-16 | — | — | WO | disclosed |
| WO-2020144094-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | BASF SE (DE) | 2020-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119357-A1 | A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF | DHPS, NISCH, UNG | LMNA 1696/4885MAPT 2165/4885JAK2 4064/4885 |
| US-12378205-B2 | Process for the preparation of triazine intermediates and a process for the preparation of UV absorbers thereof | DHPS, UNG, UMPS | LMNA 1744/4885MAPT 1906/4885JAK2 4060/4885 |
| US-20220064129-A1 | A PROCESS FOR THE PREPARATION OF UV ABSORBERS | UNG, ERCC4, UROD | LMNA 1785/4885MAPT 2536/4885JAK2 4883/4885 |
| US-12291509-B2 | Process for the preparation of UV absorbers | UNG, UROD, ERCC4 | LMNA 1777/4885MAPT 2006/4885JAK2 4884/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.